Regulation and physiological functions of G12/13-mediated signaling pathways

NeuroSignals

Volumn 17, Issue 1, 2009, Pages 55-70

  Suzuki, Nobuchika ^a   Hajicek, Nicole ^b   Kozasa, Tohru ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cell morphology and motility; Cell proliferation and transformation; Crosstalk between G12 13 mediated and other signaling pathways; G 12 13 RH RhoGEF Rho pathway; Regulation of effectors by G12; Regulation of G12 13; Regulation of G12 13 mediated signaling pathways; The cardiovascular system; The immune system; The neuronal system

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE EXCHANGE FACTOR; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

AMINO ACID SEQUENCE; ANGIOGENESIS; CARBOXY TERMINAL SEQUENCE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL STRUCTURE; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; GASTRULATION; HEART; HUMAN; IMMUNE SYSTEM; NEUROLOGIC DISEASE; NONHUMAN; OLIGOMERIZATION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; THROMBOCYTE; TUMOR CELL; VASCULAR DISEASE;

ANIMALS; CARDIOVASCULAR DISEASES; GTP-BINDING PROTEIN ALPHA SUBUNITS, G12-G13; GTP-BINDING PROTEIN REGULATORS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; IMMUNE SYSTEM; NEOPLASMS; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION; SPODOPTERA;

EID: 60149112585     PISSN: 1424862X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000186690     Document Type: Review

References (145)

1. Simon MI, Strathmann MP, Gautam N: Diversity of G proteins in signal transduction. Science 1991;252:802-808.
2. Strathmann MP, Simon MI: G alpha 12 and G alpha 13 subunits define a fourth class of G protein alpha subunits. Proc Natl Acad Sci USA 1991;88:5582-5586.
3. Althoefer H, Eversole-Cire P, Simon MI: Constitutively active Galphaq and Galpha13 trigger apoptosis through different pathways. J Biol Chem 1997;272:24380-24386.
4. Girkontaite I, Missy K, Sakk V, Harenberg A, Tedford K, Potzel T, Pfeffer K, Fischer KD: Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses. Nat Immunol 2001;2:855-862.
5. Moers A, Nieswandt B, Massberg S, Wettschureck N, Gruner S, Konrad I, Schulte V, Aktas B, Gratacap MP, Simon MI, Gawaz M, Offermanns S: G13 is an essential mediator of platelet activation in hemostasis and thrombosis. Nat Med 2003;9:1418-1422.
6. Offermanns S, Mancino V, Revel JP, Simon MI: Vascular system defects and impaired cell chemokinesis as a result of Galpha13 deficiency. Science 1997;275:533-536.
7. Ruppel KM, Willison D, Kataoka H, Wang A, Zheng YW, Cornelissen I, Yin L, Xu SM, Coughlin SR: Essential role for Galpha13 in endothelial cells during embryonic development. Proc Natl Acad Sci USA 2005;102:8281-8286.
8. Xu J, Wang F, Van Keymeulen A, Herzmark P, Straight A, Kelly K, Takuwa Y, Sugimoto N, Mitchison T, Bourne HR: Divergent signals and cytoskeletal assemblies regulate self-organizing polarity in neutrophils. Cell 2003;114:201-214.
9. Barrett K, Leptin M, Settleman J: The Rho GTPase and a putative RhoGEF mediate a signaling pathway for the cell shape changes in Drosophila gastrulation. Cell 1997;91:905-915.
10. Parks S, Wieschaus E: The Drosophila gastrulation gene concertina encodes a G alpha-like protein. Cell 1991;64:447-458.
11. Katoh H, Aoki J, Yamaguchi Y, Kitano Y, Ichikawa A, Negishi M: Constitutively active Galpha12, Galpha13, and Galphaq induce Rho-dependent neurite retraction through different signaling pathways. J Biol Chem 1998;273:28700-28707.
12. Chan AM, Fleming TP, McGovern ES, Chedid M, Miki T, Aaronson SA: Expression CDNA cloning of a transforming gene encoding the wild-type G alpha 12 gene product. Mol Cell Biol 1993;13:762-768.
13. Jiang H, Wu D, Simon MI: The transforming activity of activated G alpha 12. FEBS Lett 1993;330:319-322.
14. Voyno-Yasenetskaya TA, Pace AM, Bourne HR: Mutant alpha subunits of G12 and G13 proteins induce neoplastic transformation of Rat-1 fibroblasts. Oncogene 1994;9:2559-2565.
15. Xu N, Bradley L, Ambdukar I, Gutkind JS: A mutant alpha subunit of G12 potentiates the eicosanoid pathway and is highly oncogenic in NIH-3T3 cells. Proc Natl Acad Sci USA 1993;90:6741-6745.
16. Hiley E, McMullan R, Nurrish SJ: The Galpha12-RGS RhoGEF-RhoA signalling pathway regulates neurotransmitter release in C. elegans. EMBO J 2006;25:5884-5895.
17. Kranenburg O, Poland M, van Horck FP, Drechsel D, Hall A, Moolenaar WH: Activation of RhoA by lysophosphatidic acid and Galpha12/13 subunits in neuronal cells: induction of neurite retraction. Mol Biol Cell 1999;10:1851-1857.
18. Moers A, Nurnberg A, Goebbels S, Wettschureck N, Offermanns S: Galpha12/Galpha13 deficiency causes localized overmigration of neurons in the developing cerebral and cerebellar cortices. Mol Cell Biol 2008;28:1480-1488.
19. Jho EH, Malbon CC: Galpha12 and Galpha13 mediate differentiation of p19 mouse embryonal carcinoma cells in response to retinoic acid. J Biol Chem 1997;272:24461-24467.
20. Dettlaff-Swiercz DA, Wettschureck N, Moers A, Huber K, Offermanns S: Characteristic defects in neural crest cell-specific Galphaq/Galpha11- and Galpha12/Galpha13-deficient mice. Dev Biol 2005;282:174-182.
21. Kourlas PJ, Strout MP, Becknell B, Veronese ML, Croce CM, Theil KS, Krahe R, Ruutu T, Knuutila S, Bloomfield CD, Caligiuri MA: Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. Proc Natl Acad Sci USA 2000;97:2145-2150.
22. Kelly P, Moeller BJ, Juneja J, Booden MA, Der CJ, Daaka Y, Dewhirst MW, Fields TA, Casey PJ: The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis. Proc Natl Acad Sci USA 2006;103:8173-8178.
23. Kelly P, Stemmle LN, Madden JF, Fields TA, Daaka Y, Casey PJ: A role for the G12 family of heterotrimeric G proteins in prostate cancer invasion. J Biol Chem 2006;281:26483-26490.
24. Wirth A, Benyo Z, Lukasova M, Leutgeb B, Wettschureck N, Gorbey S, Orsy P, Horvath B, Maser-Gluth C, Greiner E, Lemmer B, Schutz G, Gutkind JS, Offermanns S: G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nat Med 2008;14:64-68.
25. Aragay AM, Collins LR, Post GR, Watson AJ, Feramisco JR, Brown JH, Simon MI: G12 requirement for thrombin-stimulated gene expression and DNA synthesis in 1321N1 astrocytoma cells. J Biol Chem 1995;270:20073-20077.
26. Jho EH, Davis RJ, Malbon CC: C-jun amino-terminal kinase is regulated by Galpha12/Galpha13 and obligate for differentiation of p19 embryonal carcinoma cells by retinoic acid. J Biol Chem 1997;272:24468-24474.
27. Martin CB, Mahon GM, Klinger MB, Kay RJ, Symons M, Der CJ, Whitehead IP: The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways. Oncogene 2001;20:1953-1963.
28. Gu JL, Muller S, Mancino V, Offermanns S, Simon MI: Interaction of G alpha(12) with G alpha(13) and G alpha(q) signaling pathways. Proc Natl Acad Sci USA 2002;99:9352-9357.
29. Offermanns S: In vivo functions of heterotrimeric G-proteins: Studies in Galpha-deficient mice. Oncogene 2001;20:1635-1642.
30. Gohla A, Schultz G, Offermanns S: Role for G(12)/G(13) in agonist-induced vascular smooth muscle cell contraction. Circ Res 2000;87:221-227.
31. Lutz S, Shankaranarayanan A, Coco C, Ridilla M, Nance MR, Vettel C, Baltus D, Evelyn CR, Neubig RR, Wieland T, Tesmer JJ: Structure of Galphaq-p63RhoGEF-RhoA complex reveals a pathway for the activation of RhoA by GPCRs. Science 2007;318:1923-1927.
32. Marinissen MJ, Servitja JM, Offermanns S, Simon MI, Gutkind JS: Thrombin protease-activated receptor-1 signals through Gq- and G13-initiated MAPK cascades regulating c-Jun expression to induce cell transformation. J Biol Chem 2003;278:46814-46825.
33. Rojas RJ, Yohe ME, Gershburg S, Kawano T, Kozasa T, Sondek J: Galphaq directly activates p63RhoGEF and trio via a conserved extension of the Dbl homology-associated pleckstrin homology domain. J Biol Chem 2007;282:29201- 29210.
34. Sagi SA, Seasholtz TM, Kobiashvili M, Wilson BA, Toksoz D, Brown JH: Physical and functional interactions of Galphaq with Rho and its exchange factors. J Biol Chem 2001;276:15445-15452.
35. Vogt S, Grosse R, Schultz G, Offermanns S: Receptor-dependent RhoA activation in G12/G13-deficient cells: genetic evidence for an involvement of gq/G11. J Biol Chem 2003;278:28743-28749.
36. Yuan J, Slice LW, Rozengurt E: Activation of protein kinase d by signaling through Rho and the alpha subunit of the heterotrimeric G protein G13. J Biol Chem 2001;276:38619-38627.
37. Hepler JR, Gilman AG: G proteins. Trends Biochem Sci 1992;17:383-387.
38. Neer EJ: Heterotrimeric G proteins: organizers of transmembrane signals. Cell 1995;80:249-257.
39. Ross EM, Wilkie TM: GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu Rev Biochem 2000;69:795-827.
40. Zerangue N, Jan LY: G-protein signaling: fine-tuning signaling kinetics. Curr Biol 1998;8:R313-R316.
41. Riobo NA, Manning DR: Receptors coupled to heterotrimeric G proteins of the G12 family. Trends Pharmacol Sci 2005;26:146-154.
42. Sugimoto N, Takuwa N, Okamoto H, Sakurada S, Takuwa Y: Inhibitory and stimulatory regulation of Rac and cell motility by the G12/13-Rho and Gi pathways integrated downstream of a single G-protein-coupled sphingosine-1-phosphate receptor isoform. Mol Cell Biol 2003;23:1534-1545.
43. 2+ in rat portal vein myocytes. J Biol Chem 1997;272:10095-10102.
44. Yamaguchi Y, Katoh H, Negishi M: N-terminal short sequences of alpha subunits of the G12 family determine selective coupling to receptors. J Biol Chem 2003;278:14936-14939.
45. Hermans E: Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors. Pharmacol Ther 2003;99:25-44.
46. 4 receptor type 1 that is specifically involved in Gi activation. J Biol Chem 2007;282:3998-4006.
47. Ponimaskin EG, Profirovic J, Vaiskunaite R, Richter DW, Voyno-Yasenetskaya TA: 5-Hydroxytryptamine 4(a) receptor is coupled to the Galpha subunit of heterotrimeric G13 protein. J Biol Chem 2002;277:20812-20819.
48. 2 receptor activity. Mol Pharmacol 2006;69:1433-1440.
49. Kozasa T, Gilman AG: Purification of recombinant G proteins from sf9 cells by hexahistidine tagging of associated subunits. Characterization of alpha 12 and inhibition of adenylyl cyclase by alpha z. J Biol Chem 1995;270:1734-1741.
50. Singer WD, Miller RT, Sternweis PC: Purification and characterization of the alpha subunit of G13. J Biol Chem 1994;269:19796-19802.
51. Kozasa T, Jiang X, Hart MJ, Sternweis PM, Singer WD, Gilman AG, Bollag G, Sternweis PC: P115 RhoGEF, a GTPase activating protein for Galpha12 and Galpha13. Science 1998;280:2109-2111.
52. Suzuki N, Nakamura S, Mano H, Kozasa T: Galpha 12 activates Rho GTPase through tyrosine-phosphorylated leukemia-associated RhoGEF. Proc Natl Acad Sci USA 2003;100:733-738.
53. Wells CD, Liu MY, Jackson M, Gutowski S, Sternweis PM, Rothstein JD, Kozasa T, Sternweis PC: Mechanisms for reversible regulation between G13 and Rho exchange factors. J Biol Chem 2002;277:1174-1181.
54. Chen Z, Singer WD, Sternweis PC, Sprang SR: Structure of the p115RhoGEF rgRGS domain-Galpha13/i1 chimera complex suggests convergent evolution of a GTPase activator. Nat Struct Mol Biol 2005;12:191-197.
55. Fukuhara S, Murga C, Zohar M, Igishi T, Gutkind JS: A novel PDZ domain containing guanine nucleotide exchange factor links heterotrimeric G proteins to Rho. J Biol Chem 1999;274:5868-5879.
56. Kreutz B, Yau DM, Nance MR, Tanabe S, Tesmer JJ, Kozasa T: A new approach to producing functional Galpha subunits yields the activated and deactivated structures of Galpha(12/13) proteins. Biochemistry 2006;45:167-174.
57. Tesmer VM, Kawano T, Shankaranarayanan A, Kozasa T, Tesmer JJ: Snapshot of activated G proteins at the membrane: the Galphaq-GRK2-gbetagamma complex. Science 2005;310:1686-1690.
58. Hart MJ, Jiang X, Kozasa T, Roscoe W, Singer WD, Gilman AG, Sternweis PC, Bollag G: Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Galpha13. Science 1998;280:2112-2114.
59. Chen Z, Wells CD, Sternweis PC, Sprang SR: Structure of the rgRGS domain of p115RhoGEF. Nat Struct Biol 2001;8:805-809.
60. Longenecker KL, Lewis ME, Chikumi H, Gutkind JS, Derewenda ZS: Structure of the RGS-like domain from PDZ-RhoGEF: linking heterotrimeric G protein-coupled signaling to Rho GTPases. Structure 2001;9:559-569.
61. Grabocka E, Wedegaertner PB: Functional consequences of G alpha 13 mutations that disrupt interaction with p115RhoGEF. Oncogene 2005;24:2155-2165.
62. Nakamura S, Kreutz B, Tanabe S, Suzuki N, Kozasa T: Critical role of lysine 204 in switch I region of Galpha13 for regulation of p115RhoGEF and leukemia-associated Rho-GEF. Mol Pharmacol 2004;66:1029-1034.
63. Chen Z, Singer WD, Wells CD, Sprang SR, Sternweis PC: Mapping the Galpha13 binding interface of the rgRGS domain of p115RhoGEF. J Biol Chem 2003;278:9912-9919.
64. Bhattacharyya R, Wedegaertner PB: Mutation of an n-terminal acidic-rich region of p115-RhoGEF dissociates alpha13 binding and alpha13-promoted plasma membrane recruitment. FEBS Lett 2003;540:211-216.
65. Jones TL, Gutkind JS: Galpha12 requires acylation for its transforming activity. Biochemistry 1998;37:3196-3202.
66. Ponimaskin E, Behn H, Adarichev V, Voyno-Yasenetskaya TA, Offermanns S, Schmidt MF: Acylation of Galpha(13) is important for its interaction with thrombin receptor, transforming activity and actin stress fiber formation. FEBS Lett 2000;478:173-177.
67. Veit M, Nurnberg B, Spicher K, Harteneck C, Ponimaskin E, Schultz G, Schmidt MF: The alpha-subunits of G-proteins G12 and G13 are palmitoylated, but not amidically myristoylated. FEBS Lett 1994;339:160-164.
68. Bhattacharyya R, Wedegaertner PB: Galpha 13 requires palmitoylation for plasma membrane localization, Rho-dependent signaling, and promotion of p115-RhoGEF membrane binding. J Biol Chem 2000;275:14992-14999.
69. Waheed AA, Jones TL: Hsp90 interactions and acylation target the G protein Galpha 12 but not Galpha 13 to lipid rafts. J Biol Chem 2002;277:32409-32412.
70. Tu Y, Wang J, Ross EM: Inhibition of brain Gz gap and other RGS proteins by palmitoylation of G protein alpha subunits. Science 1997;278:1132-1135.
71. Fields TA, Casey PJ: Phosphorylation of Gz alpha by protein kinase C blocks interaction with the beta gamma complex. J Biol Chem 1995;270:23119- 23125.
72. Kozasa T, Gilman AG: Protein kinase C phosphorylates G12 alpha and inhibits its interaction with g beta gamma. J Biol Chem 1996;271:12562-12567.
73. Lounsbury KM, Casey PJ, Brass LF, Manning DR: Phosphorylation of Gz in human platelets. Selectivity and site of modification. J Biol Chem 1991;266:22051-22056.
74. Lounsbury KM, Schlegel B, Poncz M, Brass LF, Manning DR: Analysis of Gz alpha by site-directed mutagenesis. Sites and specificity of protein kinase C-dependent phosphorylation. J Biol Chem 1993;268:3494-3498.
75. Offermanns S, Hu YH, Simon MI: Galpha12 and Galpha13 are phosphorylated during platelet activation. J Biol Chem 1996;271:26044-26048.
76. Wang J, Ducret A, Tu Y, Kozasa T, Aebersold R, Ross EM: RGSz1, a Gz-selective RGS protein in brain. Structure, membrane association, regulation by Galphaz phosphorylation, and relationship to a Gz GTPase-activating protein subfamily. J Biol Chem 1998;273:26014-26025.
77. Glick JL, Meigs TE, Miron A, Casey PJ: RGSz1, a Gz-selective regulator of G protein signaling whose action is sensitive to the phosphorylation state of Gz alpha. J Biol Chem 1998;273:26008-26013.
78. Van der Linden AM, Moorman C, Cuppen E, Korswagen HC, Plasterk RH: Hyperactivation of the G12-mediated signaling pathway in Caenorhabditis elegans induces a developmental growth arrest via protein kinase C. Curr Biol 2003;13:516-521.
79. + exchanger by G alpha 12 class of G proteins. J Biol Chem 1994;269:11802-11806.
80. Kelly P, Casey PJ, Meigs TE: Biologic functions of the G12 subfamily of heterotrimeric G proteins: growth, migration, and metastasis. Biochemistry 2007;46:6677-6687.
81. Sternweis PC, Carter AM, Chen Z, Danesh SM, Hsiung YF, Singer WD: Regulation of Rho guanine nucleotide exchange factors by G proteins. Adv Protein Chem 2007;74:189-228.
82. Hall A: Rho GTPases and the actin cytoskeleton. Science 1998;279:509-514.
83. Vazquez-Prado J, Miyazaki H, Castellone MD, Teramoto H, Gutkind JS: Chimeric G alpha i2/G alpha 13 proteins reveal the structural requirements for the binding and activation of the RGS-like (RGL)-containing Rho guanine nucleotide exchange factors (GEFs) by G alpha 13. J Biol Chem 2004;279:54283-54290.
84. Kreutz B, Hajicek N, Yau DM, Nakamura S, Kozasa T: Distinct regions of Galpha13 participate in its regulatory interactions with RGS homology domain-containing Rho-GEFs. Cell Signal 2007;19:1681-1689.
85. Chikumi H, Fukuhara S, Gutkind JS: Regulation of G protein-linked guanine nucleotide exchange factors for Rho, PDZ-Rho-GEF, and LARG by tyrosine phosphorylation: Evidence of a role for focal adhesion kinase. J Biol Chem 2002;277:12463-12473.
86. Hamazaki Y, Kojima H, Mano H, Nagata Y, Todokoro K, Abe T, Nagasawa T: Tec is involved in G-protein-coupled receptor- and integrin-mediated signalings in human blood platelets. Oncogene 1998;16:2773-2779.
87. Jiang Y, Ma W, Wan Y, Kozasa T, Hattori S, Huang XY: The G protein G alpha12 stimulates Bruton's tyrosine kinase and a rasGAP through a conserved PH/BM domain. Nature 1998;395:808-813.
88. Mao J, Xie W, Yuan H, Simon MI, Mano H, Wu D: Tec/Bmx non-receptor tyrosine kinases are involved in regulation of Rho and serum response factor by Galpha12/13. EMBO J 1998;17:5638-5646.
89. Gohla A, Harhammer R, Schultz G: The G-protein G13 but not G12 mediates signaling from lysophosphatidic acid receptor via epidermal growth factor receptor to Rho. J Biol Chem 1998;273:4653-4659.
90. Chikumi H, Barac A, Behbahani B, Gao Y, Teramoto H, Zheng Y, Gutkind JS: Homo-and hetero-oligomerization of PDZ-Rho-GEF, LARG and p115RhoGEF by their C-terminal region regulates their in vivo Rho GEF activity and transforming potential. Oncogene 2004;23:233-240.
91. Eisenhaure TM, Francis SA, Willison LD, Coughlin SR, Lerner DJ: The Rho guanine nucleotide exchange factor Lsc homo-oligomerizes and is negatively regulated through domains in its carboxyl terminus that are absent in novel splenic isoforms. J Biol Chem 2003;278:30975-30984.
92. Grabocka E, Wedegaertner PB: Disruption of oligomerization induces nucleocytoplasmic shuttling of leukemia-associated Rho guanine-nucleotide exchange factor. Mol Pharmacol 2007;72:993-1002.
93. Wells CD, Gutowski S, Bollag G, Sternweis PC: Identification of potential mechanisms for regulation of p115 RhoGEF through analysis of endogenous and mutant forms of the exchange factor. J Biol Chem 2001;276:28897-28905.
94. Kitzing TM, Sahadevan AS, Brandt DT, Knieling H, Hannemann S, Fackler OT, Grosshans J, Grosse R: Positive feedback between Dia1, LARG, and RhoA regulates cell morphology and invasion. Genes Dev 2007;21:1478-1483.
95. Bhattacharyya R, Wedegaertner PB: Characterization of G alpha 13-dependent plasma membrane recruitment of p115RhoGEF. Biochem J 2003;371:709-720.
96. Kuner R, Swiercz JM, Zywietz A, Tappe A, Offermanns S: Characterization of the expression of PDZ-RhoGEF, LARG and G(alpha)12/G(alpha)13 proteins in the murine nervous system. Eur J Neurosci 2002;16:2333-2341.
97. Togashi H, Nagata K, Takagishi M, Saitoh N, Inagaki M: Functions of a Rho-specific guanine nucleotide exchange factor in neurite retraction. Possible role of a proline-rich motif of KIAA0380 in localization. J Biol Chem 2000;275:29570-29578.
98. Banerjee J, Wedegaertner PB: Identification of a novel sequence in PDZ-RhoGEF that mediates interaction with the actin cytoskeleton. Mol Biol Cell 2004;15:1760-1775.
99. Wong K, Van Keymeulen A, Bourne HR: PDZ-RhoGEF and myosin II localize RhoA activity to the back of polarizing neutrophil-like cells. J Cell Biol 2007;179:1141-1148.
100. Taya S, Inagaki N, Sengiku H, Makino H, Iwamatsu A, Urakawa I, Nagao K, Kataoka S, Kaibuchi K: Direct interaction of insulin-like growth factor-1 receptor with leukemia-associated RhoGEF. J Cell Biol 2001;155:809-820.
101. Aurandt J, Vikis HG, Gutkind JS, Ahn N, Guan KL: The semaphorin receptor plexin-B1 signals through a direct interaction with the Rho-specific nucleotide exchange factor, LARG. Proc Natl Acad Sci USA 2002;99:12085-12090.
102. Hirotani M, Ohoka Y, Yamamoto T, Nirasawa H, Furuyama T, Kogo M, Matsuya T, Inagaki S: Interaction of plexin-B1 with PDZ domain-containing Rho guanine nucleotide exchange factors. Biochem Biophys Res Commun 2002;297:32-37.
103. Perrot V, Vazquez-Prado J, Gutkind JS: Plexin B regulates Rho through the guanine nucleotide exchange factors leukemia-associated Rho GEF (LARG) and PDZ-RhoGEF. J Biol Chem 2002;277:43115-43120.
104. Swiercz JM, Kuner R, Behrens J, Offermanns S: Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology. Neuron 2002;35:51-63.
105. Meigs TE, Fedor-Chaiken M, Kaplan DD, Brackenbury R, Casey PJ: Galpha12 and Galpha13 negatively regulate the adhesive functions of cadherin. J Biol Chem 2002;277:24594-24600.
106. Meigs TE, Fields TA, McKee DD, Casey PJ: Interaction of Galpha 12 and Galpha 13 with the cytoplasmic domain of cadherin provides a mechanism for beta-catenin release. Proc Natl Acad Sci USA 2001;98:519-524.
107. Shi CS, Sinnarajah S, Cho H, Kozasa T, Kehrl JH: G13alpha-mediated PYK2 activation. PYK2 is a mediator of G13alpha-induced serum response element-dependent transcription. J Biol Chem 2000;275:24470-24476.
108. Basile JR, Barac A, Zhu T, Guan KL, Gutkind JS: Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. Cancer Res 2004;64:5212-5224.
109. 2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells. J Biol Chem 2006;281:14026-14040.
110. Yamada T, Ohoka Y, Kogo M, Inagaki S: Physical and functional interactions of the lysophosphatidic acid receptors with PDZ domain-containing Rho guanine nucleotide exchange factors (RhoGEFs). J Biol Chem 2005;280:19358-19363.
111. Zhang H, Wang L, Kao S, Whitehead IP, Hart MJ, Liu B, Duus K, Burridge K, Der CJ, Su L: Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. Curr Biol 1999;9:1271-1274.
112. Shi CS, Kehrl JH: PYK2 links G/q)alpha and G(13)alpha signaling to NF-κB activation. J Biol Chem 2001;276:31845-31850.
113. Booden MA, Siderovski DP, Der CJ: Leukemia-associated Rho guanine nucleotide exchange factor promotes G alpha q-coupled activation of RhoA. Mol Cell Biol 2002;22:4053-4061.
114. Chikumi H, Vazquez-Prado J, Servitja JM, Miyazaki H, Gutkind JS: Potent activation of RhoA by Galpha q and Gq-coupled receptors. J Biol Chem 2002;277:27130-27134.
115. Klages B, Brandt U, Simon MI, Schultz G, Offermanns S: Activation of G12/G13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets. J Cell Biol 1999;144:745-754.
116. Ross EM: Signal sorting and amplification through G-protein-coupled receptors. Neuron 1989;3:141-152.
117. Meigs TE, Juneja J, DeMarco CT, Stemmle LN, Kaplan DD, Casey PJ: Selective uncoupling of G alpha 12 from Rho-mediated signaling. J Biol Chem 2005;280:18049-18055.
118. Wang Q, Liu M, Kozasa T, Rothstein JD, Sternweis PC, Neubig RR: Thrombin and lysophosphatidic acid receptors utilize distinct RhoGEFs in prostate cancer cells. J Biol Chem 2004;279:28831-28834.
119. Yau DM, Yokoyama N, Goshima Y, Siddiqui ZK, Siddiqui SS, Kozasa T: Identification and molecular characterization of the G alpha12-Rho guanine nucleotide exchange factor pathway in Caenorhabditis elegans. Proc Natl Acad Sci USA 2003;100:14748-14753.
120. McMullan R, Hiley E, Morrison P, Nurrish SJ: Rho is a presynaptic activator of neurotransmitter release at pre-existing synapses in C. elegans. Genes Dev 2006;20:65-76.
121. Williams SL, Lutz S, Charlie NK, Vettel C, Ailion M, Coco C, Tesmer JJ, Jorgensen EM, Wieland T, Miller KG: Trio's Rho-specific GEF domain is the missing Galpha q effector in C. elegans. Genes Dev 2007;21:2731-2746.
122. Fukuhara S, Chikumi H, Gutkind JS: RGS-containing RhoGEFs: the missing link between transforming G proteins and Rho? Oncogene 2001;20:1661-1668.
123. Radhika V, Dhanasekaran N: Transforming G proteins. Oncogene 2001;20:1607-1614.
124. Vaiskunaite R, Adarichev V, Furthmayr H, Kozasa T, Gudkov A, Voyno-Yasenetskaya TA: Conformational activation of radixin by G13 protein alpha subunit. J Biol Chem 2000;275:26206-26212.
125. 2+/calmodulin-dependent kinase, CaMKII: cross-talk with Galpha13 signaling. J Biol Chem 2005;280:39042-39049.
126. Bos JL: The ras gene family and human carcinogenesis. Mutat Res 1988;195:255-271.
127. Boettner B, Van Aelst L: The role of Rho GTPases in disease development. Gene 2002;286:155-174.
128. Sahai E, Marshall CJ: Rho-GTPases and cancer. Nat Rev Cancer 2002;2:133-142.
129. Zinovyeva M, Sveshnikova E, Visser J, Belyavsky A: Molecular cloning, sequence and expression pattern analysis of the mouse orthologue of the leukemia-associated guanine nucleotide exchange factor. Gene 2004;337:181-188.
130. Rujkijyanont P, Beyene J, Wei K, Khan F, Dror Y: Leukaemia-related gene expression in bone marrow cells from patients with the preleukaemic disorder Shwachman-diamond syndrome. Br J Haematol 2007;137:537-544.
131. Etienne-Manneville S, Hall A: Rho GTPases in cell biology. Nature 2002;420:629-635.
132. Ridley AJ: Rho GTPases and cell migration. J Cell Sci 2001;114:2713-2722.
133. Sugden PH, Clerk A: 'Stress-responsive' mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res 1998;83:345-352.
134. Maruyama Y, Nishida M, Sugimoto Y, Tanabe S, Turner JH, Kozasa T, Wada T, Nagao T, Kurose H: Galpha(12/13) mediates alpha(1)-adrenergic receptor-induced cardiac hypertrophy. Circ Res 2002;91:961-969.
135. Rubtsov A, Strauch P, Digiacomo A, Hu J, Pelanda R, Torres RM: Lsc regulates marginal-zone B cell migration and adhesion and is required for the IgM T-dependent antibody response. Immunity 2005;23:527-538.
136. Hart MJ, Sharma S, el Masry N, Qiu RG, McCabe P, Polakis P, Bollag G: Identification of a novel guanine nucleotide exchange factor for the Rho GTPase. J Biol Chem 1996;271:25452-25458.
137. Whitehead IP, Khosravi-Far R, Kirk H, Trigo-Gonzalez G, Der CJ, Kay R: Expression cloning of lsc, a novel oncogene with structural similarities to the Dbl family of guanine nucleotide exchange factors. J Biol Chem 1996;271:18643-18650.
138. Aasheim HC, Pedeutour F, Smeland EB: Characterization, expression and chromosomal localization of a human gene homologous to the mouse Lsc oncogene, with strongest expression in hematopoietic tissues. Oncogene 1997;14:1747-1752.
139. Francis SA, Shen X, Young JB, Kaul P, Lerner DJ: Rho GEF Lsc is required for normal polarization, migration, and adhesion of formyl-peptide-stimulated neutrophils. Blood 2006;107:1627-1635.
140. Guan KL, Rao Y: Signalling mechanisms mediating neuronal responses to guidance cues. Nat Rev Neurosci 2003;4:941-956.
141. Postma FR, Jalink K, Hengeveld T, Moolenaar WH: Sphingosine-1-phosphate rapidly induces Rho-dependent neurite retraction: action through a specific cell surface receptor. EMBO J 1996;15:2388-2392.
142. Vikis HG, Li W, Guan KL: The plexin-B1/Rac interaction inhibits PAK activation and enhances Sema4D ligand binding. Genes Dev 2002;16:836-845.
143. Kasai K, Takahashi M, Osumi N, Sinnarajah S, Takeo T, Ikeda H, Kehrl JH, Itoh G, Arnheiter H: The G12 family of heterotrimeric G proteins and Rho GTPase mediate sonic hedgehog signalling. Genes Cells 2004;9:49-58.
144. 2 receptor-mediated G12/13-dependent glial morphological change. Eur J Pharmacol 2006;545:100-108.
145. Suzuki N, Tsumoto K, Hajicek N, Daigo K, Tokita R, Minami S, Kodama T, Hamakubo T, Kozasa T: Activation of Leukemia-associated RhoGEF by Galpha13 with significant conformational rearrangements in the interface. J Biol Chem 2008, in press.